Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P090018/S044

Esteem

Envoy Medical Corporation · Decision date Oct 15, 2026

MEDTECHLEDGER EXPLANATIONP090018/S044

What did the FDA decide?

The FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-15, for supplement P090018/S044 to the Esteem® device from Envoy Medical Corporation. The Esteem is an active, totally implanted middle-ear hearing implant (product code OAF, Ear, Nose, Throat specialty). The supplement reason is recorded as a process change affecting a manufacturer, sterilizer, packager or supplier.

The recorded change concerns the feedthroughs: manufacturing work instructions are revised to add a cutting step for the feedthroughs, intended to reduce resonant frequency fatigue in the feedthrough pins, and to add a visual inspection step to screen for feedthrough cracks. This is a supplement-level process change, not a new approval of the whole implant system. The source record does not include supporting documents, so the review basis and any conditions of the decision remain unknown.

Whether the added steps fully address feedthrough fatigue and crack risk is not established by this record, and no clinical or performance conclusions should be drawn from it.

FDA approval order statement

revising manufacturing work instructions to add a cutting step for the feedthroughs, to mitigate resonant frequency fatigue in the feedthrough pins, and to add an additional visual inspection step to screen for feedthrough cracks
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Oct 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P090018/S044
Regulatory pathway
PMA supplement
Product code
OAF
Decision code
OK30
Decision date
Oct 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, hearing, active, middle ear, totally implanted.

Product code
OAF
FDA device class
3

For the original device and its historical approval scope, see PMA P090018. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P090018 · Original PMA

    ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEM

  2. P090018/S044 received

    Application receipt date recorded by FDA.

  3. P090018/S044 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P090018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P090018

Product / regulatory recordCompanyPathwayDecision dateSource
Envoy Medical CorporationPMA approvalMar 17, 2010FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Envoy Medical Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
4875 White Bear Pkwy., White Bear Lake, MN, 55110

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records